List of works by Eva Havrdová

A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS

scientific article published on 28 February 2019

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

scientific article published on 12 October 2016

Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.

scientific article published on 8 June 2013

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

scientific article published on 30 October 2020

Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.

scientific article published on 6 April 2016

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

scientific article published on 5 December 2014

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

scientific article published on April 2015

Contribution of different relapse phenotypes to disability in multiple sclerosis.

scientific article published on 7 April 2016

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

scientific article

Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).

scientific article published on 4 October 2012

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis

scientific article published on October 2015

Defining secondary progressive multiple sclerosis

scientific article published on 7 July 2016

Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience

scientific article

Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis

scientific article

Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up study.

scientific article

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

scientific article

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

scientific article

Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study

scientific article

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study

scientific article

Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison

scientific article

Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study

scientific article

Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study

scientific article published on 24 January 2009

Health-related quality of life in multiple sclerosis: effects of natalizumab

scientific article

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

scientific article published on 3 November 2016

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

scientific article published on 28 September 2016

Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: results from the multi-center set study

scientific article published on 30 April 2014

Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.

scientific article published on 11 September 2015

Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes

scientific article published on 2 August 2013

Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event

scientific article published on 17 April 2013

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

scientific article published on April 2017

Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: Experiences of an international panel

scientific article

Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ.

scientific article

Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis

scientific article published in 2024

Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report

scientific article published on 24 April 2007

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.

scientific article published in January 2018

Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM. Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Me

scientific article published on 24 August 2013

Oral BG-12 in multiple sclerosis

scientific article

Patients' stratification and correlation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis

scientific article published on 17 March 2009

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis

scientific article

Predictors of long-term disability accrual in relapse-onset multiple sclerosis

scientific article published on 4 May 2016

Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program

scientific article published on 13 July 2016

Real-Life Outcome in Multiple Sclerosis in the Czech Republic

scientific article published on 18 February 2019

Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment

scientific article published on 8 October 2014

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study

scientific article

Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab

scientific article published on February 2012

Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study

scientific article published on 22 January 2014

Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study

scientific article published on 17 June 2014

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.

scientific article published on 17 January 2015

The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis

scientific article

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

scientific article published on 21 July 2015

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.

scientific article published on 18 March 2009

Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations

scientific article

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

scientific article published in September 2017

Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

scientific article

Paulina is supported by:

About Paulina

Help